Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01333020
Other study ID # IFR04/2010
Secondary ID
Status Completed
Phase N/A
First received April 8, 2011
Last updated June 21, 2012
Start date November 2010
Est. completion date June 2012

Study information

Verified date June 2012
Source Institute of Food Research
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This comparative pilot study is designed to compare the rates of gastric emptying and by inference rates of digestion of two food emulsions. Two types of milk protein stabilised food emulsion will be compared, one standard emulsion preparation and one emulsion preparation cross-linked with microbial transglutaminase. The information from this study will then be compared to data on satiety and endocrine hormones from a parallel study undertaken in Finland using the same two meal formulations. The drinks will be labeled with a stable isotope of carbon and samples of breath collected every 20 minutes after consumption of the drink. This will allow gastric residence time to be calculated. The pilot will also fulfill two secondary objectives. At the same time as the breath samples are collected MRI scans of the upper abdomen will be made so that gastric volumes can be measured in order to compare the two methods of measuring gastric emptying rates. Additionally, samples of saliva will also be collected after every MRI scan for subsequent mass spectrometry analysis. These are to assess the efficacy of mass spectrometry analysis for detection of the presence of specific digestion related hormones such as ghrelin.


Recruitment information / eligibility

Status Completed
Enrollment 4
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Male (hormonal status of women would introduce more variation within small group)

- Age 20-50 years

- BMI 19-30

- Apparently healthy

- Normally eat lunch

- Willing to eat the "milkshake" style emulsion

- Provides written informed consent

Exclusion Criteria:

- You have an allergy or intolerance to rape seed oil, milk or milk proteins including lactose

- Smokers or smoked within the last year (smoking affects satiety/hunger)

- Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease

- Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported

- A history of TB or hepatitis.

- Regular (more than once in 10 days) use of antacids, laxatives

- Diagnosis with any mouth, dental, throat or digestive problem that may affect normal eating and digestion of food.

- Take prescription medication for digestive or gastrointestinal conditions.

- Volunteers taking part in another study (other than a questionnaire based study).

- Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic.

- Individuals with special dietary requirements (eg vegetarians)

- People with eating disorders (eg. anorexia, bulimia)

- If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data.

- Refusal to give permission to inform GP of participation in study

- Allergic to any of the constituents of the test meal

- Recent unexplained weight gain or loss

- History of back problems or any other condition which limit ability to repeatedly sit up and lie down

- Hiatus Hernia

- MRI scanning specific exclusion criteria

- Cardiac pacemaker or artificial heart valve

- Any surgery in the last 6 months

- Aneurysm clips (metal clips from surgery)

- Implant, pump or any medical device in the body (eg cochlear implant, neurostimulator, intra-ventricular shunt)

- Worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings

- Have artificial eyes or limbs

- Have been injured with shrapnel or bullets

- Suffer from fits, blackouts or epilepsy

- Claustrophobia sufferer

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
cross-linking of an emulsion drink
This study will assess whether a subtle change in food structure (cross-linking of interfacial protein) can alter gastric emptying rate.

Locations

Country Name City State
United Kingdom IFR Norwich Norfolk

Sponsors (2)

Lead Sponsor Collaborator
Institute of Food Research Norfolk and Norwich University Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of gastric emptying by MRI rate measured from MRI images of gastric contents 20 minute intervals over 3 hours No
Secondary Gastric emptying by C13 compare gastric emptying rates measured by MRI with those measured by 13C acetic acid breath tests. every 20 minutes over 3 hours No
Secondary mass spectrometry detection of GI tract hormones in saliva every 20 minutes over 3 hours No
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1